Discovery of selective fragment-sized immunoproteasome inhibitors-Reference-Cited by-同舟云学术

Discovery of selective fragment-sized immunoproteasome inhibitors

Published:2021-07 Issue: Volume:219 Page:113455
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Kollár Levente,Gobec Martina,Szilágyi Bence,Proj Matic,Knez Damijan,Ábrányi-Balogh Péter,Petri László,Imre Tímea,Bajusz Dávid,Ferenczy György G.,Gobec Stanislav^ORCID,Keserű György M.,Sosič Izidor

Funder

Richter Gedeon Talentum Foundation

National Research Development and Innovation Office

Hungarian Academy of Sciences

Agencija za raziskovalno dejavnost Republike Slovenije

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference81 articles.

1. A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation;Michalek;Nature,1993

2. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation;Grant;J. Immunol.,1995

3. Detailed analysis of cell cycle kinetics upon proteasome inhibition;Machiels;Cytometry,1997

4. The proteasome controls the expression of a proliferation-associated nuclear antigen ki-67;Wu;J. Cell. Biochem.,2000

5. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway;Chen;Genes Dev.,1995

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thioamides in medicinal chemistry and as small molecule therapeutic agents;European Journal of Medicinal Chemistry;2024-11

2. Structure-based mapping of the histone-binding pocket of KDM4D using functionalized tetrazole and pyridine core compounds;European Journal of Medicinal Chemistry;2024-10

3. Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update;Journal of Medicinal Chemistry;2024-05-07

4. Molecular Mechanism of Labelling Functional Cysteines by Heterocyclic Thiones;ChemPhysChem;2023-11-14

5. Design and synthesis of amino-substituted N-arylpiperidinyl-based inhibitors of the (immuno)proteasome;Acta Pharmaceutica;2023-09-01